Evidence Required for Drugs Granted Accelerated Approval

JAMA. 2017 Dec 26;318(24):2492-2493. doi: 10.1001/jama.2017.17180.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents
  • Drug Approval*
  • Humans
  • United States
  • United States Food and Drug Administration*

Substances

  • Antineoplastic Agents